SLN.L Regulatory News (SLN)

3 May 2006 17:05

SR Pharma plc ('the Company')Issue and Admission of SharesLondon 3 May 2006 - Application has been made for the admission of 2,731,739 SRPharma Ordinary Shares of 1p each with admission expected to take place on 8May 2006. The shares have been issued as a result of the exercise of warrantsat 1p per share by Maridome-Servicos de Consultoria Lda which was granted thewarrants pursuant to its role in the acquisition of Atugen AG in 2005 and thesubsequent ‚£10 million fundraising announced on 28 July 2005.Following the issue of these shares, there are now 93,043,315 SR Pharma plcOrdinary Shares of 1p each in issue.Further information:Melvyn DaviesCompany SecretarySR Pharma plcTel: +44 (0) 20 7307 1620Northbank CommunicationsTel: + 44 (0) 20 7886 8150Emma PalmerRowan MinnionENDSR PHARMA PLC